The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
- 1 October 1997
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1333 (2) , F151-F178
- https://doi.org/10.1016/s0304-419x(97)00019-x
Abstract
No abstract availableKeywords
This publication has 394 references indexed in Scilit:
- An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death InhibitorCell, 1996
- Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosisThe Journal of Pathology, 1995
- Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3Cell, 1993
- The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzymeCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- The turnover of B-cell populationsImmunology Today, 1993
- Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populationsCell, 1991
- Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogeneCell, 1991
- The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic miceCell, 1986